Modality

Operator

Operated by BioBM

For providers

Claim your profile Pricing & sponsorship How rankings work

Site

About Privacy Cookie preferences TermsTransparency

Cookies and analytics

We use essential cookies to run the site and Cloudflare Web Analytics (privacy-first, no advertising cookies) for traffic and performance. With your permission we also load Google Analytics 4. We never sell your information, and we do not use it for advertising or ad personalization. You can change the GA4 choice anytime under Cookie preferences.

Search CDMOs | cdmo.directory

Search CDMOs

169 results for “manufacturing capacity”

Sort by

Filters

Modalities

AAV / Viral Vector PlatformAntibody-Drug Conjugate (ADC)Biologics (Monoclonal Antibodies)Biologics (Other)Cell TherapyGene TherapyMicrobiome TherapeuticOligonucleotidePeptideRadiopharmaceuticalSmall MoleculeSynthetic BiologyVaccinemRNA

Development capabilities

Analytical method developmentFormulation developmentICH stability testingSolid-state characterizationCell line development

Manufacturing capabilities

Manufacturing stream

Drug Substance (DS)Drug Product (DP)

Production scale

Exploratory / CMCClinical supplyCommercial

Select biologics or small-molecule modalities above to reveal modality-specific manufacturing filters.

Regulatory clearances

FDA (US)EMA (Europe)NMPA (China)PMDA (Japan)ANVISA (Brazil)

Geographic footprint

Regions

United States
Canada
Europe
Asia-Pacific
Latin America
Middle East
Africa

Countries

Afghanistan
Åland Islands
Albania
Algeria
Andorra
Angola
Anguilla
Antigua & Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo - Brazzaville
Congo - Kinshasa
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czechia
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hong Kong SAR China
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao SAR China
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
North Macedonia
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russia
Rwanda
Samoa
San Marino
São Tomé & Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
St. Barthélemy
St. Kitts & Nevis
St. Lucia
St. Martin
St. Pierre & Miquelon
St. Vincent & Grenadines
Sudan
Suriname
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad & Tobago
Tunisia
Türkiye
Turkmenistan
Turks & Caicos Islands
Tuvalu
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe

Services

AAV Manufacturing
ADC (Antibody-Drug Conjugate) Manufacturing
ADC Payload & Linker Synthesis
API Synthesis & Manufacturing
Allogeneic Cell Therapy Manufacturing
Autologous Cell Therapy Manufacturing
Bioconjugation Services
Biologics Development & Manufacturing
CMC Analytical Development
CMC Regulatory Submission Support
Cartridge Filling
Cell Therapy Manufacturing
Cell-Line Development
Cold-Chain Storage & Logistics
Combination Product Assembly & Final Packaging
Controlled Substance Manufacturing
Downstream Processing
Extractables & Leachables Studies
Flow Chemistry & Continuous Manufacturing
Formulation Development
HPAPI Manufacturing (High-Potency)
Inhalation & Nasal Dosage Manufacturing
Lentiviral Vector Manufacturing
Lipid Nanoparticle (LNP) Formulation
Lyophilization (Freeze Drying)
Microbial Fermentation
Microbiome / Live Biotherapeutic Manufacturing
Monoclonal Antibody (mAb) Manufacturing
Oligonucleotide Manufacturing
Ophthalmic Manufacturing
Oral Solid Dosage Manufacturing
Peptide Manufacturing
Prefilled Syringe (PFS) Filling
Process Development
Quality Control Testing
Recombinant Protein Manufacturing
Secondary Packaging & Labeling
Serialization & Track-and-Trace
Small Molecule Development & Manufacturing
Solid-State Chemistry & Polymorph Screening
Stability Testing & Storage
Sterile Fill-Finish & Aseptic Manufacturing
Technology Transfer
Topical & Semi-Solid Manufacturing
Upstream Processing
Vaccine Manufacturing
Vial Filling
Viral Vector Manufacturing
mRNA Manufacturing

Reviews

Has reviewsMin overall rating

Review-based filters and average ratings stay secondary until the directory-wide review signal gate opens (see how reviews work). Result averages are hidden in listings until then.

CONTINUUS Pharmaceuticals
- CMC Analytical Development
- API Synthesis & Manufacturing
- Flow Chemistry & Continuous Manufacturing
CONTINUUS Pharmaceuticals specializes in Integrated Continuous Manufacturing (ICM)—a transformative approach that replaces traditional batch processes with end-to-end continuous flows for active pharmaceutical ingredients (APIs) and final dosage forms.
Bramble Bio
- Allogeneic Cell Therapy Manufacturing
- CMC Analytical Development

Filters

Modalities

Development capabilities

Analytical method developmentFormulation developmentICH stability testingSolid-state characterizationCell line development

Manufacturing capabilities

Manufacturing stream

Drug Substance (DS)Drug Product (DP)

Production scale

Exploratory / CMCClinical supplyCommercial

Select biologics or small-molecule modalities above to reveal modality-specific manufacturing filters.

Regulatory clearances

FDA (US)EMA (Europe)NMPA (China)PMDA (Japan)ANVISA (Brazil)

Geographic footprint

Regions

United States
Canada
Europe
Asia-Pacific
Latin America
Middle East
Africa

Countries

Afghanistan
Åland Islands
Albania
Algeria
Andorra
Angola
Anguilla
Antigua & Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo - Brazzaville
Congo - Kinshasa
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czechia
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hong Kong SAR China
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao SAR China
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
North Macedonia
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russia
Rwanda
Samoa
San Marino
São Tomé & Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
St. Barthélemy
St. Kitts & Nevis
St. Lucia
St. Martin
St. Pierre & Miquelon
St. Vincent & Grenadines
Sudan
Suriname
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad & Tobago
Tunisia
Türkiye
Turkmenistan
Turks & Caicos Islands
Tuvalu
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe

Services

AAV Manufacturing
ADC (Antibody-Drug Conjugate) Manufacturing
ADC Payload & Linker Synthesis
API Synthesis & Manufacturing
Allogeneic Cell Therapy Manufacturing
Autologous Cell Therapy Manufacturing
Bioconjugation Services
Biologics Development & Manufacturing
CMC Analytical Development
CMC Regulatory Submission Support
Cartridge Filling
Cell Therapy Manufacturing
Cell-Line Development
Cold-Chain Storage & Logistics
Combination Product Assembly & Final Packaging
Controlled Substance Manufacturing
Downstream Processing
Extractables & Leachables Studies
Flow Chemistry & Continuous Manufacturing
Formulation Development
HPAPI Manufacturing (High-Potency)
Inhalation & Nasal Dosage Manufacturing
Lentiviral Vector Manufacturing
Lipid Nanoparticle (LNP) Formulation
Lyophilization (Freeze Drying)
Microbial Fermentation
Microbiome / Live Biotherapeutic Manufacturing
Monoclonal Antibody (mAb) Manufacturing
Oligonucleotide Manufacturing
Ophthalmic Manufacturing
Oral Solid Dosage Manufacturing
Peptide Manufacturing
Prefilled Syringe (PFS) Filling
Process Development
Quality Control Testing
Recombinant Protein Manufacturing
Secondary Packaging & Labeling
Serialization & Track-and-Trace
Small Molecule Development & Manufacturing
Solid-State Chemistry & Polymorph Screening
Stability Testing & Storage
Sterile Fill-Finish & Aseptic Manufacturing
Technology Transfer
Topical & Semi-Solid Manufacturing
Upstream Processing
Vaccine Manufacturing
Vial Filling
Viral Vector Manufacturing
mRNA Manufacturing

Reviews

Has reviewsMin overall rating

Autologous Cell Therapy Manufacturing

Bramble Bio specializes in cGMP manufacturing and process development for cell therapy ATIMPs, including autologous and allogeneic therapies, with 20+ years of expertise, 16 Grade B cleanrooms, and support for over 8,000 dosed patients across 46 countries.

Sterling Pharma Solutions

ADC (Antibody-Drug Conjugate) Manufacturing
ADC Payload & Linker Synthesis
CMC Analytical Development

Small molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation.

Bachem

CMC Analytical Development
API Synthesis & Manufacturing
CMC Regulatory Submission Support

Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale.

BSP Pharmaceuticals

ADC (Antibody-Drug Conjugate) Manufacturing
ADC Payload & Linker Synthesis
CMC Analytical Development

BSP Pharmaceuticals is a CDMO specializing in development and manufacturing of cytotoxic oncology drugs, ADCs, peptides, proteins, and lipid-based formulations from preclinical GLP through commercial supply.

Ajinomoto Bio-Pharma Services

ADC (Antibody-Drug Conjugate) Manufacturing
CMC Analytical Development
Biologics Development & Manufacturing

Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.

Patheon (Thermo Fisher Pharma Services)

CMC Analytical Development
API Synthesis & Manufacturing
Biologics Development & Manufacturing

Patheon is a trusted global contract development and manufacturing organization (CDMO) partner owned by Thermo Fisher Scientific, offering 360° integrated solutions from early-stage R&D through clinical supply and commercial manufacturing.

FUJIFILM Biotechnologies

CMC Analytical Development
Biologics Development & Manufacturing
Cell-Line Development

CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities.

Samsung Biologics

ADC (Antibody-Drug Conjugate) Manufacturing
ADC Payload & Linker Synthesis
CMC Analytical Development

Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.

ProBioGen AG

AAV / Viral Vector Platform
Biologics (Monoclonal Antibodies)
Biologics (Other)

ProBioGen is a fully integrated CDMO specializing in development and GMP manufacturing of therapeutic proteins, viral vectors, and vaccines, with proprietary platforms including CHO.RiGHT® for cell line development and AGE1.CR.pIX® for vaccine production.

Cell-Easy

Allogeneic Cell Therapy Manufacturing
CMC Analytical Development
Autologous Cell Therapy Manufacturing

Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.

ACS Dobfar

CMC Analytical Development
API Synthesis & Manufacturing
Biologics Development & Manufacturing

Italian CDMO with 50 years of experience offering custom development and manufacturing of active pharmaceutical ingredients, finished dosage forms, and biotech solutions including monoclonal antibodies, with FDA and AIFA approvals.

AsymBio

ADC (Antibody-Drug Conjugate) Manufacturing
Biologics Development & Manufacturing
Monoclonal Antibody (mAb) Manufacturing

AsymBio is a CDMO providing one-stop biopharmaceutical manufacturing solutions for conjugated drugs, antibodies, and recombinant proteins, with capabilities spanning early-stage research through commercial-scale production.

Gland Pharma Limited

CMC Analytical Development
API Synthesis & Manufacturing
Sterile Fill-Finish & Aseptic Manufacturing

Gland Pharma is a vertically integrated CDMO offering sterile injectable manufacturing across vials, lyophilized, prefilled syringes, and ophthalmic formats, with four cGMP-compliant formulation facilities and four API manufacturing units, supported by R&D capabilities in formulation, analytical, and process development.

Altruist Biologics

ADC (Antibody-Drug Conjugate) Manufacturing
CMC Analytical Development
Bioconjugation Services

Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors.

Enzene Biosciences

CMC Analytical Development
Biologics Development & Manufacturing
Cell-Line Development

Global CDMO specializing in cost-effective biologics and biosimilars manufacturing using patented continuous bioprocess technology (EnzeneX®). Offers integrated drug discovery, development, and manufacturing services with facilities in India and expanding presence in the USA and Europe.

Halo Pharma

CMC Analytical Development
Cartridge Filling
Sterile Fill-Finish & Aseptic Manufacturing

Halo Pharma provides end-to-end pharmaceutical development and manufacturing for small molecule therapeutics across solids, semi-solids, oral liquids, and sterile injectables, with two North American cGMP facilities and an accelerated 16–20 week tech transfer program.

Adragos Pharma

CMC Analytical Development
CMC Regulatory Submission Support
Cold-Chain Storage & Logistics

Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.

Pyramid Pharma Services, Inc.

CMC Analytical Development
CMC Regulatory Submission Support
Cold-Chain Storage & Logistics

Pyramid Pharma Services provides GMP drug product development and manufacturing for clinical and commercial programs, including formulation, lyophilization, stability studies, and analytical services.

Symbiosis Pharmaceutical Services

ADC (Antibody-Drug Conjugate) Manufacturing
CMC Analytical Development
Cell Therapy Manufacturing

UK-based fill-finish CDMO offering rapid access to GMP aseptic manufacturing for clinical and commercial injectable drug products across mAbs, ATMPs, ADCs, RNA, peptides, vaccines, and small molecules.

Showing 41–60 of 169

Results per pageGo to page

PreviousPage 3 of 9Next

Search CDMOs

Sponsored